Deborah Dunsire, President & CEO of Lundbeck, discusses the differences between biotechs and pharmaceutical companies, emphasizing sustainability and diversity. She shares insights on successful collaborations and her personal journey, highlighting the importance of diversity in senior roles and offering advice for women in biotech. An engaging conversation covering global expansion, ESG factors, and the challenges of building a successful career.
Prioritization, efficiency, and maintaining startup spirit are crucial for larger pharmaceutical companies.
Creating sustainable solutions, promoting social responsibility, and adapting to diverse cultural contexts are vital for biotech success.
Deep dives
Deborah Danshire's Extensive Experience in Biotech and Pharma
Deborah Danshire, with over 30 years of experience in clinical and commercial management in biotech and pharma, discusses her insights from leading global biotechs and pharmaceutical companies. Her discussion covers running technology-based US biotechs, commercial giants like Millennium, and global companies like Lundbeck, focusing on neurology. Danshire emphasizes the importance of prioritization, efficiency, and maintaining the startup spirit in larger companies.
Strategic Pathways in Biotech Companies
Danshire delves into the strategic paths of startup biotech companies, highlighting the value of having a supportive board in navigating technological advancements. She stresses the need for open-mindedness in exploring different paths for value creation and the importance of partnerships in incubating and growing companies from small beginnings to widespread success.
Differences in Leading Oncology and Neurology Companies
Comparing leading oncology and neurology firms, Danshire emphasizes the shared purpose of addressing unmet needs in healthcare. She discusses how companies like Lundbeck focus on mental health to restore brain health, highlighting the cultural differences between US and European healthcare approaches. Danshire underscores the significance of creating sustainable solutions and adapting to diverse cultural contexts.
Emphasizing ESG Principles in Business Practices
Danshire highlights the increasing focus on environmental, social, and governance (ESG) principles in biotech, discussing strategies to minimize carbon footprints and promote social responsibility. She emphasizes the importance of creating diverse, inclusive workplaces and driving positive impacts in local communities. Danshire advocates for aligning business practices with ESG goals and sustaining partnerships based on mutual respect and clear communication.
Cowen analyst Yaron Werber speaks to Deborah Dunsire, President & CEO of Lundbeck, about the similarities and differences between leading smaller, US-based biotechs and larger pharmaceutical companies with a global footprint. We discuss the importance of having a long-term outlook focused on sustainability, social responsibility, and diversity, as well as the key elements underlying successful collaborations. Finally, Deborah shares her personal journey and offers her take on what it takes to build a successful career.
For Disclosures, click here bit.ly/3cPHkNW
https://go.td.com/PodcastDisclosure
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode